Expression of brachyury in hemangioblastoma: Potential use in differential diagnosis

American Journal of Surgical Pathology

Volumn 36, Issue 7, 2012, Pages 1052-1057

  Barresi, Valeria ^a   Vitarelli, Enrica ^a   Branca, Giovanni ^a   Antonelli, Manila ^b   Giangaspero, Felice ^b   Barresi, Gaetano ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

brachyury; clear cell renal carcinoma; hemangioblastoma; meningioma

Indexed keywords

BRACHYURY PROTEIN; FETOPROTEIN; T BOX TRANSCRIPTION FACTOR; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CEREBELLUM TUMOR; CHEMISTRY; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HEMANGIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; ITALY; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; MENINGIOMA; METASTASIS; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CEREBELLAR NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FETAL PROTEINS; HEMANGIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; ITALY; KIDNEY NEOPLASMS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; T-BOX DOMAIN PROTEINS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84863323155     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31824f4ce3     Document Type: Article

References (32)

1. Abou-Hamden A, Koszyca B, Carney PG, et al. Metastasis of renal cell carcinoma to haemangioblastoma of the spinal cord in von Hippel-Lindau disease: case report and review of the literature. Pathology. 2003;35:224-227. (Pubitemid 36870597)
2. Acikalin MF, Oner U, Tel N, et al. Supratentorial hemangioblastoma: a case report and review of the literature. Arch Pathol Lab Med. 2003;127:e382-e384.
3. Aldape KD, Plate KH, Vortmeyer AO, et al. Hemangioblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumors of the Central Nervous System. Lyon: IARCC press; 2007:184-186.
4. Bret P, Streichenberger N, Guyotat J. Metastasis of renal carcinoma to a cerebellar hemangioblastoma in a patient with von Hippel Lindau disease: a case report. Br J Neurosurg. 1999;13:413-416. (Pubitemid 29371722)
5. Carney EM, Banerjee P, Ellis CL, et al. PAX2(+)/PAX8(+)/inhibin A(+) immunoprofile in hemangioblastoma: a helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system. Am J Surg Pathol. 2011;35: 262-267.
6. Conway JE, Chou D, Clatterbuck RE, et al. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery. 2001;48:55-63. (Pubitemid 32039827)
7. Glä sker S, Li J, Xia JB, et al. Hemangioblastomas share protein expression with embryonal hemangioblast progenitor cell. Cancer Res. 2006;66:4167-4172.
8. Gouldesbrough DR, Bell JE, Gordon A. Use of immunohistochemical methods in the differential diagnosis between primary cerebellar haemangioblastoma and metastatic renal carcinoma. J Clin Pathol. 1988;41:861-865.
9. Hamazaki S, Nakashima H,Matsumoto K, et al. Metastasis of renal cell carcinoma to central nervous system hemangioblastoma in two patients with von Hippel-Lindau disease. Pathol Int. 2001;51: 948-953. (Pubitemid 34175523)
10. Hoang MP, Amirkhan RH. Inhibin alpha distinguishes hemangioblastoma from clear cell renal cell carcinoma. Am J Surg Pathol. 2003;27:1152-1156. (Pubitemid 36909538)
11. Ingold B, Wild PJ, Nocito A, et al. Renal cell carcinoma marker reliably discriminates central nervous system hemangioblastoma from brain metastases of renal cell carcinoma. Histopathology. 2008;52:674-681. (Pubitemid 351600042)
12. Jung SM, Kuo TT. Immunoreactivity of CD10 and inhibin alpha in differentiating hemangioblastoma of central nervous system from metastatic clear cell renal cell carcinoma. Mod Pathol. 2005;18: 788-794.
13. Kilic N, Feldhaus S, Kilic E, et al. Brachyury expression predicts poor prognosis at early stages of colorectal cancer. Eur J Cancer. 2011;47:1080-1085.
14. Kispert A, Koschorz B, Herrmann BG. The T protein encoded by brachyury is a tissue-specific transcription factor. EMBO J. 1995;14: 4763-4772.
15. Mottolese C, Stan H, Giordano F, et al. Metastasis of clear cell renal cell carcinoma to cerebellar hemangioblastoma in von Hippel Lindau disease: rare or not investigated? Acta Neurochir. 2001; 143:1059-1063. (Pubitemid 33022758)
16. Oviedo A, Pang D, Zovickian J, et al. Clear cell meningioma: case report and review of the literature. Pediatr Dev Pathol. 2005;8:386-390. (Pubitemid 41204485)
17. Palena C, Polev DE, Tsang KY, et al. The human T-box mesodermal transcription factor brachyury is a candidate target for T-cell-mediated cancer immunotherapy. Clin Cancer Res. 2007; 13:2471-2478. (Pubitemid 46698599)
18. Park DM, Zhuang Z, Chen L, et al. Von Hippel-Lindau diseaseassociated hemangioblastomas are derived from embryologic multipotent cells. PLoS Med. 2007;4:e60.
19. Perry A, Louis DN, Scheithauer BW, et al. Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumors of the Central Nervous System. Lyon: IARCC press; 2007:164-172.
20. Provot S, Schipani E. Molecular mechanism of endochondral bone development. Biochem Biophys Res Commun. 2005;328:658-665. (Pubitemid 40208303)
21. Rivera AL, Takei H, Zhai J, et al. Useful immunohistochemical markers in differentiating hemangioblastoma versus metastatic renal cell carcinoma. Neuropathology. 2010;30:580-585.
22. Roy S, Chu A, Trojanowski JQ, et al. D2-40, a novel monoclonal antibody against the M2A antigen as a marker to distinguish hemangioblastomas from renal cell carcinomas. Acta Neuropathol. 2005;109:497-502. (Pubitemid 40909194)
23. Sangoi AR, Dulai MS, Beck AH, et al. Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation. Am J Surg Pathol. 2009;33:669-681.
24. Sangoi AR, Karamchandani J, Lane B, et al. Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases. Mod Pathol. 2011;24:425-429.
25. Sharma RR, Cast IP, O'Brien C. Supratentorial haemangioblastoma not associated with Von Hippel Lindau complex or polycythaemia: case report and literature review. Br J Neurosurg. 1995;9:81-84.
26. Shively SB, Falke EA, Li J, et al. Developmentally arrested structures preceding cerebellar tumors in von Hippel-Lindau disease. Mod Pathol. 2011;24:1023-1030.
27. Takei H, Bhattacharjee MB, Rivera A, et al. New immunohistochemical markers in the evaluation of central nervous system tumors: a review of 7 selected adult and pediatric brain tumors. Arch Pathol Lab Med. 2007;131:234-241.
28. Takeuchi H, Hashimoto N, Kitai R, et al. A report of supratentorial leptomeningeal hemangioblastoma and a literature review. Neuropathology. 2008;28:98-102.
29. Tirabosco R, Mangham DC, Rosenberg AE, et al. Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue. Am J Surg Pathol. 2008;32: 572-580. (Pubitemid 351459578)
30. Vujovic S, Henderson S, Presneau N, et al. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol. 2006;209:157-165. (Pubitemid 43805410)
31. Weinbreck N, Marie B, Bressenot A, et al. Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining. Am J Surg Pathol. 2008;32:1051-1059.
32. Yoshida A, Oda R, Shibahara J, et al. Soft-tissue hemangioblastoma of the retroperitoneum: a case study and review of the literature. Appl Immunohistochem Mol Morphol. 2010;18:479-482.